Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke

Journal of Emergency Medicine

Volumn 45, Issue 1, 2013, Pages

  Gorski, Elizabeth M ^a,b   Schmidt, Michael J ^c  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; LISINOPRIL; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AFRICAN AMERICAN; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARM WEAKNESS; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CEREBRAL ARTERY DISEASE; DRUG INFUSION; EMERGENCY WARD; FIBRINOLYTIC THERAPY; GOUT; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OROLINGUAL ANGIOEDEMA; PARESTHESIA; PRIORITY JOURNAL; TONGUE EDEMA; URTICARIA; ANGIOEDEMA; CHEMICALLY INDUCED; COMPLICATION; STROKE; TONGUE DISEASES; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED DISORDER; TONGUE DISEASE;

AGED; ANGIOEDEMA; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; MALE; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TONGUE DISEASES;

EID: 84897345912     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2013.02.004     Document Type: Article

References (2)

1. Hill MD, Lye T, Moss H., et al Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003;60:1525-7.
2. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment. An in vitro experimental approach. Stroke 2002;33:1712-6.